AEON Biopharma, Inc. SEC filings AEON
AEON Biopharma, Inc. has 361 filings in SEC EDGAR's recent list, going back to Dec 23, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Nov 3, 2026 | — |
| 424B4 | Prospectus | Jul 15, 2026 | — |
| S-1MEF | Filing | Jul 13, 2026 | — |
| S-1/A | Amended registration statement | Jul 9, 2026 | — |
| S-1 | Registration statement | Jul 8, 2026 | — |
| S-8 | Employee stock plan registration | Mar 31, 2026 | — |
| 424B3 | Prospectus | Feb 18, 2026 | — |
| S-3 | Shelf registration | Feb 9, 2026 | — |
| 424B5 | Prospectus supplement | Jun 16, 2025 | — |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| 424B5 | Prospectus supplement | Jan 7, 2025 | — |
| 424B5 | Prospectus supplement | Jan 6, 2025 | — |
| 424B3 | Prospectus | Nov 13, 2024 | — |
| 424B5 | Prospectus supplement | Aug 21, 2024 | — |
| S-3 | Shelf registration | Aug 15, 2024 | — |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| 424B3 | Prospectus | Aug 5, 2024 | — |
| S-1/A | Amended registration statement | Jul 23, 2024 | — |
| S-1/A | Amended registration statement | May 31, 2024 | — |
| S-1/A | Amended registration statement | Apr 2, 2024 | — |
| S-8 | Employee stock plan registration | Apr 1, 2024 | — |
| S-1/A | Amended registration statement | Nov 24, 2023 | — |
| S-1/A | Amended registration statement | Oct 23, 2023 | — |
| S-1 | Registration statement | Aug 18, 2023 | — |
| S-4MEF | Form s-4mef | Jul 18, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| S-4/A | Filing | May 9, 2023 | — |
| S-4/A | Form s-4/a | May 1, 2023 | — |
| S-4/A | Form s4 | Mar 10, 2023 | — |
| S-4/A | Filing | Feb 9, 2023 | — |
| S-4 | Registration for a merger or exchange | Dec 27, 2022 | — |
| 424B4 | Prospectus | Feb 11, 2021 | — |
| S-1MEF | Filing | Feb 9, 2021 | — |
| S-1/A | Amended registration statement | Jan 29, 2021 | — |
| S-1 | Registration statement | Jan 21, 2021 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AEON (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1837607
- Former names
- Priveterra Acquisition Corp. (until Jul 24, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.